Preoperative Resistance Training in Patients Scheduled for Total Hip Arthroplasty
Launched by UNIVERSITY OF SOUTHERN DENMARK · Jul 15, 2010
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND:
Osteoarthritis of the hip is a common condition among elderly. In Denmark 8000 people underwent operation with total hip arthroplasty in 2007, due to osteoarthritis (Danish Register of hip arthroplasty 2007)).
The number of hip arthroplasties has been doubled the last decade mostly due to an increase in the age group 70-79 years (Danish Register of Hip Arthroplasty 2007). The population of elderly has been increased by to the demographic changes (Danish Statistics). A larger need for treatment could be expected in the future due to this development.
The indications of surgery...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients scheduled for total hip arthroplasty due to primary osteoarthritis with an age of 50 years or older.
- • Patients in the intervention group must participate in 80% of the training as a minimum and more than 2 skipped sessions in a row is not allowed.
- Exclusion Criteria:
- • Rheumatoid arthritis (RA) or other types of arthritis other than primary osteoarthritis.
- • Uremia
- • Cancer
- • Systemic treatment with glucocorticoid more than 3 months the last 5 years with a daily dose \> 5 mg.
- • Fracture of the hip (ipsi or contralateral)
- • Other fracture of the lower extremities the last year
- • Other condition with reduced function (ex polio seq.)
- • Weight above 135 kg
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, , Denmark
Patients applied
Trial Officials
Andreas EB Hermann, MD
Principal Investigator
University of Southern Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials